Lay-off looms large

Discussion in 'AstraZeneca' started by anonymous, May 7, 2020 at 7:55 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Ummmmmmm, ya right!!!!!
     

  2. anonymous

    anonymous Guest

    Go fuck yourself
     
  3. anonymous

    anonymous Guest

    The egos of these people ..... good luck! Don’t let the door hit ya!
     
  4. anonymous

    anonymous Guest

    Yes- $100k+ per year is the only way to get a motivated, college educated person to "play the game" (of pretending they have any control over their numbers, when in reality they have none), and actually going out and collecting signatures, when the average person would be completely unmotivated due to lack of control over anything and unwanted/stepped on by 90% of the people they interact with all day. The average person at an average salary would just sit home and record fake calls because they can. Until there is no need at all for drug reps, they will need to be paid 6 figures (plus perks) because anything less than that is not enough to get someone decent to put up with the fake everything and never ending bullshit of this job. If there was a way to pay reps less and not lose $, im sure some drug company's six sigma would have figured it out by now.
     
  5. anonymous

    anonymous Guest

    To #64, a big YUP.

    Back in the 90's, had responsibility for a blockbuster. Covered the geography by my lonesome. Loved it that way. In 2000, in prep for Nexium and Crestor the territory that had one, now had 8.... yup 8. It was a joke and unsustainable. Now, we have 4-5 depending on which way the wind blows but still more than we need. One rep per territory w/ a ESS or RST as the "special" person. Hopefully when Breztri launches, resp kicks back Farxiga to diabetes and everyone then worries about their own TA.
     
  6. anonymous

    anonymous Guest

    You are, unfortunately, spot on.
    This job could be so satisfying and rewarding if it went back to being real sales and got rid of all the made-for-management metrics, trackers and meeting BS. Cut most of the DMs and half the RMs and this could happen. Think of the savings as well.
     
  7. anonymous

    anonymous Guest

    Field sales jobs will be safe for years on end. The board of directors will always be happy when stock is at its highest.
     
  8. anonymous

    anonymous Guest

    Farxiga's two main patents expire on October 4, 2020. How will this affect CVMD headcount? Is it safe to be in the diabetes division come fall time?
     
  9. anonymous

    anonymous Guest


    Yup and cut PSS's in half. Think of THOSE savings. No need for so many living the all day lie.
     
  10. anonymous

    anonymous Guest

    Most DMs exist only to justify their job. Not to lead or develop their sales reps.
     
  11. anonymous

    anonymous Guest

    Give DM's a break. You think most are happy with the situation we are in? Marketing runs the show DM's are told what to do and how to do it. How do you coach messaging? Let's face it. It's a no brainer. We are not supposed to have in depth disease state discussions. So what's to coach? Over time DM's come up with busy work that means nothing to justify their jobs. The vast majority of DMs come from the sales force. They know the score. They play the same bullshit game reps play but get paid more money for it and have an office day where they can sit home. My friends your DM has a job to do. Give them what they want and you will be left alone.
     
  12. anonymous

    anonymous Guest

    The DMs make a lot more money than we do and they have an "office day" or should we refer to it as a vacation day every week? If it were an office day, why don't they do the reports instead of sending them to us to do?
     
  13. anonymous

    anonymous Guest


    DM here....because I can!
     
  14. anonymous

    anonymous Guest

    I salute you.
     
  15. anonymous

    anonymous Guest

    Any truthful insider info on the future of the diabetes division in the coming months??? Covid-19 has made primary care a nightmare in the northeast and by the time we return to the field, a second wave is expected to begin again shortly after our return. Access was already virtually nonexistent even before this pandemic. Are the jobs of reps in specialty divisions safer than those in primary care? Is access any better for specialty reps in this Covid-19 world that will be the new normal for the foreseeable future? Thx
     
  16. anonymous

    anonymous Guest

    We will be selling Farxiga for at least eight more years and the pipeline is strong. Always keep in mind that upper and mid level management only exist with massive headcount in the field. Our jobs will be trying to make the metrics look pretty at least through this year and then who knows how all of this will go next year.
     
  17. anonymous

    anonymous Guest

    You don't know what you're talking about. Shut up rep.